Africa's First Fully Integrated Vaccine Plant
Sector: Manufacturing (Industrial) • Location: Cape Town, South Africa
Source: Fierce Pharma
Biovac, a South African pharmaceutical company, has secured a $108.3 million financing package to build Africa's first end-to-end, multi-vaccine production plant. The project will be located at Biovac's Cape Town manufacturing site and is expected to be completed by 2028. The facility will initially produce oral cholera vaccines and eventually vaccines for polio, pneumonia, and meningitis, with a
- Status
- Prospective
- Sector
- Manufacturing (Industrial)
- Location
- Cape Town, South Africa
- Updated
- 22 Jul 2026
- Source
- Fierce Pharma
ConstructChat
Ask ConstructChat about Africa's First Fully Integrated Vaccine Plant
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Biovac, a South African pharmaceutical company, has secured a $108.3 million financing package to build Africa's first end-to-end, multi-vaccine production plant. The project will be located at Biovac's Cape Town manufacturing site and is expected to be completed by 2028. The facility will initially produce oral cholera vaccines and eventually vaccines for polio, pneumonia, and meningitis, with a capacity of up to 40 million doses per year. The project aims to address 40% of the global cholera vaccine supply gap and support regional markets served by UNICEF and Gavi, the Vaccine Alliance. It will also generate over 340 skilled jobs and an estimated 7,000 indirect jobs. |
Original sector | Healthcare |
Budget |
Location
Country | South Africa |
City | Cape Town |
Source
Source | Fierce Pharma |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2026-04-23 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project